Atlas Trials

High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy

Clinical trial NCT01236456 · WITHDRAWN

Trial details

NCT number
NCT01236456
Sponsor
Stony Brook University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Inflammatory Demyelinating Polyneuropathy
Start date
2003-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.